- The Wall Street Journal•last month
Mylan isn’t the only company riding the EpiPen roller coaster of late. The pharmaceutical company Monday said it plans to sell a generic version of EpiPen, its best-selling product. This news came after ...
- TheStreet.com•last month
Adamis Pharmaceuticals (ADMP) is waiting for approval for a generic alternative to Mylan's (MYL) EpiPen.
Adamis Pharmaceuticals Corporation (ADMP)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||3.10 x 100|
|Ask||3.55 x 2000|
|Day's Range||3.20 - 3.44|
|52wk Range||2.50 - 10.98|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.53|
|Avg Vol (3m)||786,896|
|Dividend & Yield||N/A (N/A)|